Logo
Loading Weather...

IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC

Business March 6, 2026 0 Views
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
Source: https://finance.yahoo.com/rss/topstories - Read Original

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!